Investors breathe easier on the news, pushing Sigma’s share price 6% higher on Monday as the group reaffirms that expansion at home, not in Britain, is its priority.
Sigma, which owns the fast-growing Chemist Warehouse network, confirms it is no longer pursuing the Boots business currently on the block from private equity owner Sycamore Partners. The potential deal would have required Sigma to tap markets for billions in fresh equity or debt funding to finance the acquisition.
Market concern spiked last week when Sigma acknowledged it was in discussions about the UK retailer, prompting questions about execution risk. Management now stresses that Australia remains the main focus for its growth strategy.
Shareholders had been particularly unsettled by the sheer scale of the proposed transaction relative to Sigma’s existing operations. Funding a multibillion-dollar offshore buyout raised fears of dilution, balance sheet strain and distraction from domestic priorities.
Analysts also questioned whether Boots’ store footprint and operating model could be easily aligned with Chemist Warehouse’s larger-format, discount-driven approach. Strategically, many investors saw more value in deepening Sigma’s position in the Australian pharmacy and health retail market rather than stretching into a complex UK turnaround.
